Literature DB >> 11477198

Genetic disorders of neonatal respiratory function.

F S Cole1, A Hamvas, L M Nogee.   

Abstract

Genetic risk for respiratory distress in infancy has been recognized with increasing frequency in neonatal intensive care units. Reports of family clusters of affected infants and of ethnic- and gender-based respiratory phenotypes point to the contribution of inheritance. Similarly, different outcomes among gestationally matched infants with comparable exposures to oxygen, mechanical ventilation, or nutritional deficiency also suggest a genetic risk for respiratory distress. Examples of inherited deficiency of surfactant protein B in both humans and genetically engineered murine lineages illustrate the importance of identifying markers of genetic risk. In contrast to developmental, inflammatory, or nutritional causes of respiratory distress that may resolve as infants mature, genetic causes result in both acute and chronic (and potentially irreversible) respiratory failure. The availability of clinically useful genetic markers of risk for respiratory distress in infancy will permit development of rational strategies for treatment of genetic lung disorders of infancy and more accurate counseling of families whose infants are at genetic risk for development of respiratory distress at birth or during early childhood. We review examples of genetic variations known to be associated with or cause respiratory distress in infancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11477198     DOI: 10.1203/00006450-200108000-00001

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  11 in total

1.  l7Rn6 encodes a novel protein required for clara cell function in mouse lung development.

Authors:  Rodrigo Fernández-Valdivia; Ying Zhang; Sonia Pai; Michael L Metzker; Armin Schumacher
Journal:  Genetics       Date:  2005-09-12       Impact factor: 4.562

2.  Use of surfactants.

Authors:  Sunil K Sinha
Journal:  J Pediatr Pharmacol Ther       Date:  2007-10

Review 3.  Surfactant therapy: the current practice and the future trends.

Authors:  Khalid Altirkawi
Journal:  Sudan J Paediatr       Date:  2013

4.  ABCA3 mutations associated with pediatric interstitial lung disease.

Authors:  Janine E Bullard; Susan E Wert; Jeffrey A Whitsett; Michael Dean; Lawrence M Nogee
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

5.  A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with lucinactant, beractant, or poractant alfa.

Authors:  Carlos G Guardia; Fernando R Moya; Sunil Sinha; Phillip D Simmons; Robert Segal; Jay S Greenspan
Journal:  J Pediatr Pharmacol Ther       Date:  2012-07

6.  Interstitial lung disease in two brothers with novel compound heterozygous ABCA3 mutations.

Authors:  Hiroshi Kitazawa; Kunihiko Moriya; Hidetaka Niizuma; Kengo Kawano; Yuka Saito-Nanjo; Toru Uchiyama; Takeshi Rikiishi; Yoji Sasahara; Osamu Sakamoto; Yasuhiro Setoguchi; Shigeo Kure
Journal:  Eur J Pediatr       Date:  2013-02-27       Impact factor: 3.183

7.  Surfactant protein B deficiency and gene mutations for neonatal respiratory distress syndrome in China Han ethnic population.

Authors:  Xiaojuan Yin; Fanping Meng; Yan Wang; Lu Xie; Xiangyong Kong; Zhichun Feng
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

8.  Evidence for a conserved function in synapse formation reveals Phr1 as a candidate gene for respiratory failure in newborn mice.

Authors:  Robert W Burgess; Kevin A Peterson; Michael J Johnson; Jeffrey J Roix; Ian C Welsh; Timothy P O'Brien
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 9.  Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome.

Authors:  Margaret W Leigh; Jessica E Pittman; Johnny L Carson; Thomas W Ferkol; Sharon D Dell; Stephanie D Davis; Michael R Knowles; Maimoona A Zariwala
Journal:  Genet Med       Date:  2009-07       Impact factor: 8.822

10.  Disruption of sorting nexin 5 causes respiratory failure associated with undifferentiated alveolar epithelial type I cells in mice.

Authors:  Sun-Kyoung Im; HyoBin Jeong; Hyun-Woo Jeong; Kyong-Tai Kim; Daehee Hwang; Machiko Ikegami; Young-Yun Kong
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.